Characteristics of moCEBPA vs biCEBPA patients
| Characteristic . | moCEBPA . | biCEBPA . | P . | 
|---|---|---|---|
| Age, y | .69 | ||
| Median | 62 | 57 | |
| Range | 16-78 | 20-84 | |
| Sex | |||
| Female | 23 (72) | 23 (48) | .04 | 
| WBC count, ×109/L | 31/32 | 47/48 | .47 | 
| Median | 30 | 28 | |
| Range | 0.4-188 | 1.3-408.6 | |
| Hemoglobin, g/dL | 29/32 | 44/48 | .13 | 
| Median | 9.1 | 10 | |
| Range | 2.7-13.2 | 6.4-13.8 | |
| Platelet count, ×109/L | 28/32 | 47/48 | .09 | 
| Median | 52 | 32 | |
| Range | 3-291 | 3-151 | |
| Bone marrow blasts, % | 19/32 | 40/48 | .65 | 
| Median | 85 | 71 | |
| Range | 30-95 | 20-100 | |
| LDH, U/dL | 20/32 | 36/48 | .67 | 
| Median | 392 | 479 | |
| Range | 152-2666 | 205-2510 | 
| Characteristic . | moCEBPA . | biCEBPA . | P . | 
|---|---|---|---|
| Age, y | .69 | ||
| Median | 62 | 57 | |
| Range | 16-78 | 20-84 | |
| Sex | |||
| Female | 23 (72) | 23 (48) | .04 | 
| WBC count, ×109/L | 31/32 | 47/48 | .47 | 
| Median | 30 | 28 | |
| Range | 0.4-188 | 1.3-408.6 | |
| Hemoglobin, g/dL | 29/32 | 44/48 | .13 | 
| Median | 9.1 | 10 | |
| Range | 2.7-13.2 | 6.4-13.8 | |
| Platelet count, ×109/L | 28/32 | 47/48 | .09 | 
| Median | 52 | 32 | |
| Range | 3-291 | 3-151 | |
| Bone marrow blasts, % | 19/32 | 40/48 | .65 | 
| Median | 85 | 71 | |
| Range | 30-95 | 20-100 | |
| LDH, U/dL | 20/32 | 36/48 | .67 | 
| Median | 392 | 479 | |
| Range | 152-2666 | 205-2510 | 
Data represent number or n (%) of patients, unless otherwise indicated. Bold indicates significant P values.
LDH, lactate dehydrogenase; WBC, white blood cell.